CN106290822B - D-二聚体免疫胶乳微球制备方法及应用 - Google Patents
D-二聚体免疫胶乳微球制备方法及应用 Download PDFInfo
- Publication number
- CN106290822B CN106290822B CN201610604464.2A CN201610604464A CN106290822B CN 106290822 B CN106290822 B CN 106290822B CN 201610604464 A CN201610604464 A CN 201610604464A CN 106290822 B CN106290822 B CN 106290822B
- Authority
- CN
- China
- Prior art keywords
- dimer
- solution
- latex
- buffer solution
- immunized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 119
- 239000000539 dimer Substances 0.000 title claims abstract description 115
- 239000004816 latex Substances 0.000 title claims abstract description 90
- 229920000126 latex Polymers 0.000 title claims abstract description 90
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 239000004793 Polystyrene Substances 0.000 claims abstract description 54
- 229920002223 polystyrene Polymers 0.000 claims abstract description 54
- 238000001514 detection method Methods 0.000 claims abstract description 40
- 230000002708 enhancing effect Effects 0.000 claims abstract description 15
- 238000004879 turbidimetry Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000003149 assay kit Methods 0.000 claims abstract description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 9
- 239000012190 activator Substances 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 96
- 239000007853 buffer solution Substances 0.000 claims description 60
- 206010010254 Concussion Diseases 0.000 claims description 54
- 230000009514 concussion Effects 0.000 claims description 54
- 239000003153 chemical reaction reagent Substances 0.000 claims description 36
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 34
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 30
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 26
- 150000001718 carbodiimides Chemical class 0.000 claims description 22
- 239000000872 buffer Substances 0.000 claims description 19
- 239000004471 Glycine Substances 0.000 claims description 17
- HNXGGWNCFXZSAI-UHFFFAOYSA-N 2-morpholin-2-ylethanesulfonic acid Chemical compound OS(=O)(=O)CCC1CNCCO1 HNXGGWNCFXZSAI-UHFFFAOYSA-N 0.000 claims description 16
- 230000004913 activation Effects 0.000 claims description 16
- 239000003755 preservative agent Substances 0.000 claims description 15
- 230000002335 preservative effect Effects 0.000 claims description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
- 229930006000 Sucrose Natural products 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Substances [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 13
- 239000003381 stabilizer Substances 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 12
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 11
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 11
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 11
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 10
- 229940033663 thimerosal Drugs 0.000 claims description 10
- 239000008363 phosphate buffer Substances 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 229930195725 Mannitol Natural products 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000594 mannitol Substances 0.000 claims description 7
- 235000010355 mannitol Nutrition 0.000 claims description 7
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000007983 Tris buffer Substances 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 4
- 239000000701 coagulant Substances 0.000 claims description 4
- 238000011010 flushing procedure Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 229960000633 dextran sulfate Drugs 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 2
- 229960001484 edetic acid Drugs 0.000 claims description 2
- 229960003511 macrogol Drugs 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 4
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 2
- 229910052796 boron Inorganic materials 0.000 claims 2
- 235000009508 confectionery Nutrition 0.000 claims 2
- 230000001934 delay Effects 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 230000003139 buffering effect Effects 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000008878 coupling Effects 0.000 abstract description 12
- 238000010168 coupling process Methods 0.000 abstract description 12
- 238000005859 coupling reaction Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 239000003154 D dimer Substances 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 230000023555 blood coagulation Effects 0.000 abstract description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 2
- 238000010382 chemical cross-linking Methods 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 description 10
- 239000010836 blood and blood product Substances 0.000 description 7
- 229940125691 blood product Drugs 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000004520 agglutination Effects 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000006471 dimerization reaction Methods 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- 108010052295 fibrin fragment D Proteins 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- -1 trihydroxy methyl amino Chemical group 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- JDXQWYKOKYUQDN-UHFFFAOYSA-N 3-hydroxypyrrolidine-2,5-dione Chemical class OC1CC(=O)NC1=O JDXQWYKOKYUQDN-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010000196 Factor XIIIa Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical group CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 108010073651 fibrinmonomer Proteins 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
试剂盒实施例编号 | 实施例4 | 实施例5 | 实施例6 | 实施例7 |
人血待测品中DD浓度 | 0.78mg/L | 0.82mg/L | 0.93mg/L | 0.71mg/L |
Cv% | 4.33% | 4.79% | 4.52% | 4.98% |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610604464.2A CN106290822B (zh) | 2016-07-28 | 2016-07-28 | D-二聚体免疫胶乳微球制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610604464.2A CN106290822B (zh) | 2016-07-28 | 2016-07-28 | D-二聚体免疫胶乳微球制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106290822A CN106290822A (zh) | 2017-01-04 |
CN106290822B true CN106290822B (zh) | 2018-06-19 |
Family
ID=57662849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610604464.2A Active CN106290822B (zh) | 2016-07-28 | 2016-07-28 | D-二聚体免疫胶乳微球制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106290822B (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107589266A (zh) * | 2017-08-09 | 2018-01-16 | 上海原科实业发展有限公司 | 一种血管内皮生长因子胶乳增强免疫比浊试剂盒及其应用 |
CN108008125A (zh) * | 2017-12-18 | 2018-05-08 | 江苏浩欧博生物医药股份有限公司 | 一种适用于免疫磁珠的冻干工作液和免疫磁珠冻干品及其制备方法 |
CN108181247A (zh) * | 2017-12-20 | 2018-06-19 | 河南联博生物科技有限公司 | 一种胶乳增强免疫比浊法定量检测黄曲霉毒素b1的试剂 |
CN110133270A (zh) * | 2018-02-09 | 2019-08-16 | 长沙文瀚生物技术有限责任公司 | 一种增强免疫抑制比浊抗体筛选试剂及其制作和使用方法 |
CN109187955A (zh) * | 2018-08-01 | 2019-01-11 | 深圳市锦瑞生物科技有限公司 | 一种用于检测d-二聚体的试剂盒及其检测方法 |
CN109444412A (zh) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | 一种用于微型化学发光免疫分析系统的宠物d-二聚体检测试剂盒 |
JP2020148580A (ja) * | 2019-03-13 | 2020-09-17 | 東ソー株式会社 | 添加剤によるdダイマー測定での偽高値の抑制 |
CN111077304A (zh) * | 2019-12-31 | 2020-04-28 | 深圳市瀚德标检生物工程有限公司 | 一种羧基乳胶微球与抗体的偶联方法 |
CN111856039A (zh) * | 2020-03-16 | 2020-10-30 | 苏州德沃生物技术有限公司 | 一种测定全血降钙素原的免疫比浊方法学试剂盒 |
CN111999506B (zh) * | 2020-08-20 | 2023-03-31 | 安徽伊普诺康生物技术股份有限公司 | 一种d-二聚体检测试剂盒及其制备方法 |
CN112730848B (zh) * | 2020-12-29 | 2022-03-22 | 中生北控生物科技股份有限公司 | 一种检测视黄醇结合蛋白的试剂盒及方法 |
CN112904009B (zh) * | 2021-02-19 | 2022-03-18 | 山东莱博生物科技有限公司 | 一种检测糖基化cd59的磁性微球检测试剂盒及其应用 |
CN112858698B (zh) * | 2021-04-25 | 2021-11-09 | 北京沃森赛瑟生物技术有限公司 | 一种d-二聚体胶乳增强免疫比浊试剂盒及其制备方法 |
CN113933503A (zh) * | 2021-10-20 | 2022-01-14 | 上海艾瑞德生物科技有限公司 | 一种用于检测目标抗体与微球偶联效率的试剂盒及其方法和应用 |
CN113985029A (zh) * | 2021-10-25 | 2022-01-28 | 中元汇吉生物技术股份有限公司 | 一种适用于提升免疫比浊试剂稳定性的组合物 |
CN114137223A (zh) * | 2021-11-25 | 2022-03-04 | 安徽大千生物工程有限公司 | 一种快速测定igf-1的胶乳增强免疫比浊法测定试剂盒及其制备使用方法 |
CN115032382A (zh) * | 2021-11-26 | 2022-09-09 | 杭州伊佰新生物技术有限公司 | 一种铁蛋白检测试剂盒及其制备方法 |
CN114264824A (zh) * | 2021-12-13 | 2022-04-01 | 河南迈达斯实业有限公司 | 一种胶乳增强免疫比浊法测定d-二聚体含量的试剂盒及d-二聚体含量的检测方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006064807A1 (ja) * | 2004-12-14 | 2006-06-22 | Arkray, Inc. | 検体前処理方法およびそれを用いた免疫測定方法 |
WO2007074864A1 (ja) * | 2005-12-28 | 2007-07-05 | Advanced Life Science Institute, Inc. | アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法 |
EP2146207A1 (en) * | 2007-11-21 | 2010-01-20 | Arkray, Inc. | Measurement reagent, immune nephelometry using the same, and analyte analysis tool |
CN101819202A (zh) * | 2010-05-06 | 2010-09-01 | 上海太阳生物技术有限公司 | D-二聚体(D-Dimer)测定试剂盒(胶乳免疫比浊法) |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
CN102628868A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒 |
CN204228713U (zh) * | 2014-11-13 | 2015-03-25 | 江苏达骏生物科技有限公司 | 用于d-二聚体检测的检测卡 |
-
2016
- 2016-07-28 CN CN201610604464.2A patent/CN106290822B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006064807A1 (ja) * | 2004-12-14 | 2006-06-22 | Arkray, Inc. | 検体前処理方法およびそれを用いた免疫測定方法 |
WO2007074864A1 (ja) * | 2005-12-28 | 2007-07-05 | Advanced Life Science Institute, Inc. | アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法 |
EP2146207A1 (en) * | 2007-11-21 | 2010-01-20 | Arkray, Inc. | Measurement reagent, immune nephelometry using the same, and analyte analysis tool |
CN101819202A (zh) * | 2010-05-06 | 2010-09-01 | 上海太阳生物技术有限公司 | D-二聚体(D-Dimer)测定试剂盒(胶乳免疫比浊法) |
CN101968492A (zh) * | 2010-10-29 | 2011-02-09 | 厦门大学附属中山医院 | 检测脂联素的颗粒增强免疫透射比浊试剂盒及其制备方法 |
CN102628868A (zh) * | 2011-12-30 | 2012-08-08 | 北京九强生物技术股份有限公司 | 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒 |
CN204228713U (zh) * | 2014-11-13 | 2015-03-25 | 江苏达骏生物科技有限公司 | 用于d-二聚体检测的检测卡 |
Also Published As
Publication number | Publication date |
---|---|
CN106290822A (zh) | 2017-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106290822B (zh) | D-二聚体免疫胶乳微球制备方法及应用 | |
CN106324239B (zh) | C-反应蛋白免疫胶乳微球制备方法及应用 | |
WO2018129885A1 (zh) | 一种全血c反应蛋白检测试剂盒 | |
CN107422129A (zh) | 一种超敏的心肌肌钙蛋白i磁微球免疫比浊检测方法及检测试剂盒 | |
CN105339794A (zh) | 用于检测光度测定法的前带效应的方法 | |
CN105067615B (zh) | 一种基于酰胺基团纳米胶乳增强比浊法动物c‑反应蛋白的检测试剂盒及检测方法 | |
CN105842458A (zh) | 一种降钙素原测定试剂盒及其降钙素原的含量的测定方法 | |
EP1801590B1 (en) | Method of assaying antigen and reagent therefor | |
CN111122874A (zh) | 基于胶乳增强免疫比浊法测定ln的试剂盒及其制备使用方法 | |
CN106405076A (zh) | D‑二聚体检测试剂盒及其制备方法 | |
CN110806487A (zh) | 一种用于人肝素结合蛋白检测的试剂盒及其制备方法 | |
CN111239418A (zh) | 一种基于胶乳增强免疫比浊法测定ana的试剂盒及其制备使用方法 | |
CN109633161B (zh) | 一种基于胶乳增强免疫比浊法的降钙素原检测试剂盒 | |
CN110940815B (zh) | 定量测定猫血清淀粉样蛋白a的乳胶免疫比浊检测试剂盒 | |
CN116908443A (zh) | 一种检测pla2r抗体的化学发光试剂盒 | |
CN111999506A (zh) | 一种d-二聚体检测试剂盒及其制备方法 | |
CN107328933A (zh) | 磁微粒增强免疫比浊检测盒及其应用 | |
CN106053828A (zh) | 一种测定全量程‑c反应蛋白的试剂盒及其制备方法 | |
CN112698034B (zh) | 一种癌胚抗原cea的检测试剂盒 | |
CN112326954B (zh) | 一种快速定量检测d-二聚体的均相荧光免疫的试剂 | |
CN114965986A (zh) | 用于检测血液中可溶性生长刺激表达基因2蛋白(st2)的试剂盒 | |
CN112485444A (zh) | 基于乳胶增强免疫比浊法测定d-二聚体的试剂盒及其制备方法 | |
US10048267B2 (en) | Methods and compositions for assaying blood levels of legumain | |
CN110672862B (zh) | 一种血型检测卡及其制备方法 | |
CN106093419A (zh) | 一种测定d‑二聚体的试剂盒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method and application of D-dimer immuno latex microspheres Effective date of registration: 20191202 Granted publication date: 20180619 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN KING DIAGNOSTIC TECHNOLOGY Co.,Ltd. Registration number: Y2019420000035 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211203 Granted publication date: 20180619 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN KING DIAGNOSTIC TECHNOLOGY Co.,Ltd. Registration number: Y2019420000035 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation and application of D-dimer immune latex microspheres Effective date of registration: 20211215 Granted publication date: 20180619 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN KING DIAGNOSTIC TECHNOLOGY Co.,Ltd. Registration number: Y2021420000140 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230106 Granted publication date: 20180619 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN KING DIAGNOSTIC TECHNOLOGY Co.,Ltd. Registration number: Y2021420000140 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation and application of D-dimer immune latex microspheres Effective date of registration: 20230109 Granted publication date: 20180619 Pledgee: Guanggu Branch of Wuhan Rural Commercial Bank Co.,Ltd. Pledgor: WUHAN KING DIAGNOSTIC TECHNOLOGY Co.,Ltd. Registration number: Y2023420000011 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |